AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MACITENTAN 10 Mg ;

10 registrations across 1 African market— 10 active

Markets with MACITENTAN 10 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Macitentan- EVAPHARMA
Film Coated Tablets
🇪🇬EgyptEVAPHARMA for Pharmaceutical Industries ( EVAPHARMA)active
Westentan
Film Coated Tablets
🇪🇬EgyptWestern Pharmaceuticals Industriesactive
Opsumit
Film Coated Tablets
🇪🇬EgyptJanssen pharmaceutica NVactive
Neamacitol
Film Coated Tablets
🇪🇬EgyptOctober Pharmaactive
Zakitenix
Film Coated Tablets
🇪🇬EgyptNew Apple Pharmaactive
Westentan
Film Coated Tablets
🇪🇬EgyptWestern Pharmaceuticals Industriesactive
Macitentan- EVAPHARMA
Film Coated Tablets
🇪🇬EgyptEVAPHARMA for Pharmaceutical Industries ( EVAPHARMA)active
Opsumit
Film Coated Tablets
🇪🇬EgyptJanssen pharmaceutica NVactive
Zakitenix
Film Coated Tablets
🇪🇬EgyptNew Apple Pharmaactive
Neamacitol
Film Coated Tablets
🇪🇬EgyptOctober Pharmaactive

MACITENTAN 10 Mg ; in Africa — Regulatory Overview

MACITENTAN 10 Mg ; is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.